title: Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors.
abstract: Our earlier studies have shown that changes in serum corticosterone levels played an important role in the acquisition of sensitization to MK-801, a non-competitive NMDA receptor antagonist. Dopaminergic mechanisms are found to be particularly important in the development of sensitization; hence in the present study we assessed the binding of [3H]SCH 23390 at brain dopaminergic D1 receptors, after administration of MK-801 (0.4 mg/kg), in rats in which corticosterone synthesis was inhibited by metyrapone (150 + 50 mg/kg). Such metyrapone pretreatment prevented the increases in serum corticosterone level induced by MK-801. The binding studies, using receptor autoradiography, were performed in the following brain structures: the striatum, nucleus accumbens, olfactory tubercle and substantia nigra. Metyrapone per se did not change or slightly increased D1 receptor binding in the substantia nigra, while in other brain structures tested it decreased the number of these receptors by about 30%. MK-801 increased the level of D1 receptors in the nucleus accumbens core and olfactory tubercle, being without effect in the remaining brain structures tested. In rats which were pretreated with metyrapone, the effect of MK-801 on D1 receptors was inhibited in the nucleus accumbens core only. In substantia nigra, metyrapone provoked the MK-801-induced decrease in D1 receptors whereas in all other structures MK-801 reversed the effects of metyrapone on D1 receptors. Additionally, the effect of metyrapone and MK-801 on grooming behavior induced by D1 receptor agonist SKF 38393 (10 mg/kg) was tested. Metyrapone did not influence grooming induced by SKF 38393, but significantly potentiated the inhibitory effect of MK-801 on this behavior. Finally, we found that metyrapone did not influence the expression of the sensitization induced by MK-801. Our results seem not to support hypothesis that MK-801 evokes enhancement of dopaminergic neurotransmission (at the level of D1 receptors) via corticosterone liberation, since in most brain regions studied inhibition of increases in corticosterone level did not prevent MK-801-induced effects on D1 receptors. The present study may suggest that NMDA receptors are involved in the corticosterone-dependent regulation of the density of the D1 receptors.
authors.affiliation: Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Czyrak
authors.forename: M
authors.initials: M
authors.lastname: Maćkowiak
authors.forename: K
authors.initials: K
authors.lastname: Fijał
authors.forename: A
authors.initials: A
authors.lastname: Chocyk
authors.forename: K
authors.initials: K
authors.lastname: Wedzony
mesh_terms: D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000494:pharmacology; D000818:Animals; D001345:Autoradiography; D001552:Benzazepines / Q000378:metabolism; D001921:Brain / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D003345:Corticosterone / Q000097:blood; D016291:Dizocilpine Maleate / Q000494:pharmacology* / Q000633:toxicity; D018491:Dopamine Agonists / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000378:metabolism; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology* / Q000633:toxicity; D006120:Grooming / Q000187:drug effects; D006948:Hyperkinesis / Q000139:chemically induced / Q000503:physiopathology; D008297:Male; D008797:Metyrapone / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D017447:Receptors, Dopamine D1 / Q000187:drug effects* / Q000378:metabolism
chemical_list: D001552:Benzazepines; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D018691:Excitatory Amino Acid Antagonists; D017447:Receptors, Dopamine D1; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D016291:Dizocilpine Maleate; D003345:Corticosterone; D008797:Metyrapone